Tagbo, Michael M.

HRN: 22-23-02  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2022
CEFTRIAXONE 1G (VIAL)
11/17/2022
11/23/2022
IVTT
2g
Q24
Elevated WBC With Perisitent LBM
Waiting Final Action 
11/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/17/2022
11/23/2022
IVTT
500mg
Q8
Elevated WBC With Perisitent LBM
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: